Skip to main content

Table 1 Baseline characteristics, before matching

From: Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

 

Cohort iC + CRT

Cohort CRT

45–55 Gy

55+ Gy

 

45–55 Gy

55+ Gy

 

N

%

N

%

P

N

%

N

%

P

Facility

0.39

    

0.0031

 Nonacademic

335

56

71

52

 

672

63

163

72

 

 Academic

259

43

65

47

 

390

37

58

26

 

 NA

7

1

1

1

 

4

0

4

2

 

Age

1

    

0.0081

 < 65

303

50

69

50

 

474

44

122

54

 

 ≥ 65

298

50

68

50

 

592

56

103

46

 

 NA

0

0

0

0

 

0

0

0

0

 

Gender

0.047

    

1

 Female

297

49

81

59

 

514

48

109

48

 

 Male

304

51

56

41

 

552

52

116

52

 

 NA

0

0

0

0

 

0

0

0

0

 

Race

0.88

    

0.18

 White

493

82

115

84

 

869

82

190

84

 

 Black

81

13

17

12

 

168

16

27

12

 

 Other

19

3

3

2

 

20

2

7

3

 

 NA

8

1

2

1

 

9

1

1

0

 

Insurance

0.31

    

0.095

 None

12

2

2

1

 

28

3

7

3

 

 Nonprivate

320

53

63

46

 

633

59

117

52

 

 Private

265

44

70

51

 

391

37

99

44

 

 NA

4

1

2

1

 

14

1

2

1

 

Income

1

    

0.45

 Above median

389

65

90

66

 

546

51

118

52

 

 Below median

207

34

47

34

 

503

47

97

43

 

 NA

5

1

0

0

 

17

2

10

4

 

Residential setting

0.33

    

0.077

 Metro

488

81

114

83

 

807

76

151

67

 

 Urban

77

13

16

12

 

189

18

53

24

 

 Rural

10

2

5

4

 

34

3

7

3

 

 NA

26

4

2

1

 

36

3

14

6

 

Charlson-Deyo Score

1

    

0.25

 0–1

575

96

131

96

 

1006

94

217

96

 

 ≥ 2

26

4

6

4

 

60

6

8

4

 

 NA

0

0

0

0

 

0

0

0

0

 

Year of diagnosis

0.016

    

< 0.001

 2004–2007

52

9

7

5

 

317

30

92

41

 

 2008–2011

245

41

74

54

 

529

50

105

47

 

 2012–2015

304

51

56

41

 

220

21

28

12

 

 NA

0

0

0

0

 

0

0

0

0

 

Primary tumor site

0.068

    

0.014

 Head

411

68

94

69

 

764

72

140

62

 

 Body

171

28

43

31

 

271

25

74

33

 

 Tail

19

3

0

0

 

31

3

11

5

 

 NA

0

0

0

0

 

0

0

0

0

 

Tumor size (cm)

0.70

    

0.018

 < 3.8

265

44

65

47

 

486

46

82

36

 

 ≥ 3.8

283

47

64

47

 

448

42

111

49

 

 NA

53

9

8

6

 

132

12

32

14

 

Clinical N stage

0.44

    

0.70

 0

367

61

89

65

 

692

65

143

64

 

 1

234

39

48

35

 

374

35

82

36

 

 NA

0

0

0

0

 

0

0

0

0

 

Chemotherapy

0.20

    

0.74

 Single agent

166

28

30

22

 

789

74

164

73

 

 Multi agent

435

72

107

78

 

277

26

61

27

 

 NA

0

0

0

0

 

0

0

0

0

 

Total radiation dose (Gy)

< 0.001

    

< 0.001

 Median

50.4

 

59.4

  

50.4

 

59.4

  

 IQR

50.4–52.5

56.0–59.4

 

50.4–52.0

57.5–60.0

 

Fraction

< 0.001

    

< 0.001

 Median

28

 

30

  

28

 

32

  

 IQR

27–28

28–33

 

26–28

30–33

 
  1. iC induction chemotherapy, CRT chemoradiation, IQR interquartile range, NA not available